The effect of 6 months migalastat treatment on podocyte globotriaosylceramide inclusion content, independent of mosaicism, in females with Fabry disease and amenable GLA mutations

Project: Research project

Description

The effect of 6 months migalastat treatment on podocyte globotriaosylceramide inclusion content, independent of mosaicism, in females with Fabry disease and amenable GLA mutations
StatusFinished
Effective start/end date6/5/186/4/19

Funding

  • University of Washington

Fingerprint

Fabry Disease
Podocytes
Mosaicism
Mutation
migalastat
globotriaosylceramide